Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematin therapy in porphyric attacks

C A Pierach, I Bossenmaier, R Cardinal

    Klinische Wochenschrift
    |August 15, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The medical bookshelf.

    Postgraduate medicine·2016
    Same author

    The Medical Bookshelf.

    Postgraduate medicine·2016
    Same author

    The medical bookshelf.

    Postgraduate medicine·2016
    Same author

    Editor's Mail.

    Postgraduate medicine·2016
    Same author

    The Gordon Wilson Lecture: Some Aspects of the Porphyrin Problem in Relation to Clinical Medicine.

    Transactions of the American Clinical and Climatological Association·2011
    Same author

    Effect of varying the phosphorus content of dairy cow diets on losses of phosphorus in overland flow following surface applications of manure.

    Journal of environmental quality·2011
    Same journal

    Klinische Wochenschrift·2020
    Same journal

    Pathological anatomy of malnutrition.

    Klinische Wochenschrift·2010
    Same journal

    Consequences of chronic malnutrition in the clinical picture of internal diseases.

    Klinische Wochenschrift·2010
    Same journal

    Use of stable isotopes in biology.

    Klinische Wochenschrift·2010
    Same journal

    About applications of radioactive indicators in medicine and physiology.

    Klinische Wochenschrift·2010
    Same journal

    Early diagnosis and assessment of the activity of pulmonary tuberculosis based on serological examinations.

    Klinische Wochenschrift·2010
    See all related articles

    Hemat in effectively treats porphyric attacks, improving patient outcomes. This therapy is well-tolerated and recommended for porphyria relapses.

    Area of Science:

    • Biochemistry
    • Clinical Medicine
    • Genetics

    Background:

    • Porphyric attacks are acute, life-threatening neurological episodes.
    • Several types of porphyria exist, including acute intermittent porphyria, variegate porphyria, and hereditary coproporphyria.
    • Current treatment options for porphyric attacks can be limited.

    Purpose of the Study:

    • To evaluate the efficacy and safety of hematin in treating patients experiencing porphyric attacks.
    • To assess the clinical response and biochemical changes associated with hematin therapy.

    Main Methods:

    • A retrospective analysis of 57 patients treated with hematin during porphyric attacks.
    • Patients included those with acute intermittent porphyria, variegate porphyria, and hereditary coproporphyria.

    Related Experiment Videos

  • Clinical outcomes and porphyrin precursor levels were monitored.

    • Main Results:

    • Over 90% of patients demonstrated a favorable clinical response to hematin.
    • A significant decline in porphyrin precursors was observed in more than 90% of patients.
    • Hematin was well-tolerated with minimal adverse effects.

    Conclusions:

    • Hematin is an effective treatment for acute porphyric attacks.
    • The therapy leads to both biochemical improvements and positive clinical outcomes.
    • Hematin should be considered a primary treatment option for porphyric relapses.